Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$54.42
-3.22%
Mkt Cap $4.24B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
Implied Upside
+27.2%
Consensus $69.20 vs current $54.42
NASDAQ·Healthcare·Biotechnology
$54.42
-3.22%
Mkt Cap $4.24B
Buy
12
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
+27.2%
Consensus $69.20 vs current $54.42